Puretech Health Share Price (PRTC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Puretech Health Plc	LSE:PRTC	London	Ordinary Share	GB00BY2Z0H74	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-18.00	-6.34%	266.00	349,071	16:35:00

Bid Price		Offer Price	High Price	Low Price	Open Price
260.00		270.00	285.00	246.00	285.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	12.84	-53.67	-12.55		752

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:59:29	O	1,261	267.269	GBX

Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Geiger Counter (GCS), Valirx (VAL)

Puretech Health (PRTC) Latest News

Puretech Health News

Date	Time	Source	Headline
16/9/2019	16:40	UKREG	PureTech Health PLC Second Price Monitoring Extn
16/9/2019	16:35	UKREG	PureTech Health PLC Price Monitoring Extension
09/9/2019	13:04	ALNC	PureTech Chair Ito Resigns Amid MIT Media Lab Epstein Funding Scandal
09/9/2019	12:07	UKREG	PureTech Health PLC Second Price Monitoring Extn
09/9/2019	12:02	UKREG	PureTech Health PLC Price Monitoring Extension
09/9/2019	07:13	ALNCF	Alliance News Flash Headline
09/9/2019	07:00	UKREG	PureTech Health PLC PureTech Announces Board Change
07/9/2019	23:14	BW	PureTech Announces Board Change
06/9/2019	16:41	UKREG	PureTech Health PLC Second Price Monitoring Extn
06/9/2019	16:35	UKREG	PureTech Health PLC Price Monitoring Extension

More Puretech Health News

Puretech Health Takeover Rumours

Puretech Health (PRTC) Share Charts

1 Year Puretech Health Chart

1 Month Puretech Health Chart

Intraday Puretech Health Chart

Puretech Health (PRTC) Discussions and Chat

Puretech Health Forums and Chat

Date	Time	Title	Posts
05/9/2019	14:20	PureTech Health - innovative healthcare	407
22/7/2018	21:35	PureTech Health (PRTC) One to Watch Monday	-

Add a New Thread

Puretech Health (PRTC) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2019-09-20 15:59:29	267.27	1,261	3,370.26	O
2019-09-20 15:56:57	266.03	100	266.03	O
2019-09-20 15:48:10	266.00	408	1,085.28	O

View all Puretech Health trades in real-time

Puretech Health (PRTC) Top Chat Posts

Date	Subject
21/9/2019 09:20	Puretech Health Daily Update: Puretech Health Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 284p. Puretech Health Plc has a 4 week average price of 246p and a 12 week average price of 220p. The 1 year high share price is 307p while the 1 year low share price is currently 155p. There are currently 282,679,696 shares in issue and the average daily traded volume is 73,291 shares. The market capitalisation of Puretech Health Plc is £751,927,991.36. Read Full Thread Reply
10/6/2019 19:41	lendmeafiver: I agree, always been very impressed by Daphne Zohar. Share price seems to be going vertical. Read Full Thread Follow Reply
04/6/2019 17:38	lendmeafiver: Yes I had noticed Woodford wasn’t in here, share price flying again. Read Full Thread Follow Reply
02/5/2019 18:08	lendmeafiver: Agree. Surely given recent progress an ipo or other transaction at Gelesis has to be on the cards, will have a huge impact on the Prtc share price I expect. Read Full Thread Follow Reply
16/4/2019 20:31	lendmeafiver: Been looking forward to the approval of Gelesis100 and pleased to see it has created a bit of interest here. When I first invested here I took the view that Gelesis very much covered the downside with all the other puretech pipelines being almost for free in the share price, I very much believe that to be the case now in my opinion. Like the name Plenity also. Read Full Thread Follow Reply
16/4/2019 02:19	rambutan2: Just reminding myself that: PureTech's percentage ownership of Gelesis is approximately 20.5% on a diluted basis and approximately 19.2% on a fully-diluted basis. Note that: PureTech also has the right to receive a 2% royalty on the sales of certain Gelesis products, including Gelesis100 (aka PLENITY). http://uk.advfn.com/stock-market/london/puretech-PRTC/share-news/PureTech-Health-PLC-Gelesis-Raises-30M-Prepares/76832837 Read Full Thread Follow Reply
19/3/2019 21:24	rambutan2: edwardt, i suppose it's in response to this capital raise... https://uk.advfn.com/stock-market/NASDAQ/TORC/share-news/resTORbio-Inc-Announces-Proposed-Public-Offering/79496189 Although in the results they said... "Cash and Cash Equivalents: Cash, cash equivalents and marketable securities were $108.0 million as of December 31, 2018, as compared to $53.3 million as of December 31, 2017. The Company expects that current cash, cash equivalents and marketable securities as of December 31, 2018 will be sufficient to fund its operating expenses at least into the second quarter of 2020." So it's not as though they are desperate. Ultimately, of course, the share price will be trial results driven. Read Full Thread Follow Reply
31/12/2018 11:07	lendmeafiver: Vedanta puretech holding was 71.5% I believe, now 63%, they raised usd27, values the company at around usd200m and puretechs holding at circa usd120m fully diluted, about right? Worth about 45p per share alone, please note calculated on an iPhone calculator whilst drinking in a coffee shop so please correct me if I’m wrong! Very encouraging to see some very high profile new investors directly into Vedanta. Anyway I think it’s been a very sold year of progress here, both in the business and a reasonable share price performance, remains hugely undervalued in my opinion, plenty to look forward to in 2019. Read Full Thread Follow Reply
12/7/2018 15:03	lendmeafiver: Very encouraging news, I purchased a few more here this week, well below ipo and share issue prices of course, I expect that at some stage this year there will be sufficient newsflow to really move the share price closer to the brokers targets of circa £3 Read Full Thread Follow Reply
21/2/2018 14:23	edwardt: my takes were chances of two more ipos in next 6 months. they are also going to go coy on valuation methodology given sensitivity around pricing on ipo and second rounds - all makes sense to me but will prove hard for analysts to model which could result in vol in share price. i want to sit tight for a decade on this one. Read Full Thread Follow Reply
10/1/2018 10:52	healzo2: I imagine pretty much as you would expect. Great emphasis placed on the award winning, world class calibre of the team, and the pipeline of innovative and potentially lucrative products. Biome / second brain considerations seen as becoming more prominent in public consciousness going forward. Share price seen as heading upwards of 800p in the next 5 years. Possible headwinds listed as the need for further capitalisation and naturally testing failures. One of the better and more convincingly written pamphlets I've read over the years. Seemed based on true conviction rather than usual ramping rubbish. Read Full Thread Follow Reply

Puretech Health share price data is direct from the London Stock Exchange

Your Recent History

LSE

PRTC

Puretech H..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190921 15:59:54